Finally, in this study, a thrombotic environment was artificially recreated by adding the exogenous chymase prior to halo coagulation, thus allowing the enzyme to be sequestered within the blood clot as previously observed in human DVT (15), prior to fibrinolysis. The gene discussed is CMA1; the disease is deep vein thrombosis.